Can biotechnology put patients’ needs ahead of profits?

These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that 'waxed lyrical' about the importance of accelerating vaccine access worldwide, then failed to support an intellectual property waiver that would expand global production of COVID-19 vaccines.

Prime Minister Justin Trudeau, pictured outside Rideau Hall on July 26, 2023, after shuffling his cabinet. 'Let’s hope the cabinet shuffle breathes ethical reflection into the government’s pursuit of excellence in the biotechnology sphere,' writes Sharon Batt.The Hill Times photograph by Andrew Meade

Opinion

BY SHARON BATT

September 11, 2023

When Canada launched a biotechnology strategy in 1998, feminist scholar Nandita Sharma opposed it. The strategy was focused on economic benefits, she said. It didn�...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy